Dylan E OSullivan
Overview
Explore the profile of Dylan E OSullivan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
73
Citations
1042
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sutherland R, OSullivan D, Ruan Y, Chow K, Mah B, Kim D, et al.
Cancers (Basel)
. 2024 Nov;
16(22).
PMID: 39594779
Background/objectives: Risk prediction models (RPMs) for colorectal cancer (CRC) could facilitate risk-based screening. Models incorporating biomarkers may improve the utility of current RPMs. We performed a systematic review of studies...
2.
Bishay K, Meng Z, Khan R, Gupta M, Ruan Y, Vaska M, et al.
Gastroenterology
. 2024 Nov;
168(3):568-586.
PMID: 39515394
Background & Aims: Endoscopic retrograde cholangiopancreatography (ERCP)-related adverse events (AEs) are associated with morbidity, mortality, and health care expenditure. We aimed to assess incidences and comparisons of ERCP AEs. Methods:...
3.
Gotto G, Yip S, Shayegan B, OSullivan D, Wallis C, Basappa N, et al.
Can Urol Assoc J
. 2024 Oct;
19(1):E25-E35.
PMID: 39470659
Introduction: Treatment intensification beyond androgen deprivation therapy (ADT) has shown survival benefit in patients with metastatic castration-sensitive prostate cancer (mCSPC). There is a need to better understand how these novel...
4.
Warkentin M, Cheung W, Brenner D, OSullivan D
Cancer Epidemiol Biomarkers Prev
. 2024 Oct;
34(1):174-181.
PMID: 39422543
Background: Improvements in cancer control have led to a drastic increase in cancer survivors who may be at an elevated risk of developing subsequent primary cancers (SPC). In this study,...
5.
Heer E, Ruan Y, Warkentin M, Hilsden R, Rabeneck L, OSullivan D, et al.
Cancer Epidemiol
. 2024 Aug;
92:102640.
PMID: 39106619
Introduction: Colorectal cancer (CRC) incidence among adults younger than 50 years has increased in recent decades, leading to some advocating for lowering the age to start CRC screening. Here, we...
6.
Kokts-Porietis R, OSullivan D, Nelson G, Courneya K, Cook L, Friedenreich C
Am J Epidemiol
. 2024 Jun;
193(12):1701-1711.
PMID: 38918029
We examined associations between modifiable and nonmodifiable cancer-related risk factors measured at endometrial cancer diagnosis and during early survivorship (~3 years postdiagnosis) with second primary cancer (SPC) risk among 533...
7.
OSullivan D, Kolinsky M, Shokar S, Jarada T, Cheung W
Clin Genitourin Cancer
. 2024 Jun;
22(5):102115.
PMID: 38890099
Background: Data are needed to improve the current understanding of clinical management and characteristics of patients with advanced prostate cancer (PC) treated with androgen receptor pathway inhibition (ARPI) therapy. Methods:...
8.
Basmadjian R, OSullivan D, Quan M, Lupichuk S, Xu Y, Cheung W, et al.
Genes (Basel)
. 2024 May;
15(5).
PMID: 38790221
Early-onset breast cancer (EoBC), defined by a diagnosis <40 years of age, is associated with poor prognosis. This study investigated the mutational landscape of non-metastatic EoBC and the prognostic relevance...
9.
OSullivan D, Ruan Y, Farah E, Hutchinson J, Hilsden R, Brenner D
Cancer Epidemiol
. 2024 May;
91:102578.
PMID: 38749340
Purpose: The incidence of early-onset (<50 years of age) colorectal cancer (eoCRC) has been steadily increasing in high-income countries including Canada. Despite this increase in incidence, the etiology of eoCRC...
10.
Yusuf A, Boyne D, OSullivan D, Brenner D, Cheung W, Mirza I, et al.
BMC Med Res Methodol
. 2024 Mar;
24(1):63.
PMID: 38468224
Background: Laboratory data can provide great value to support research aimed at reducing the incidence, prolonging survival and enhancing outcomes of cancer. Data is characterized by the information it carries...